CU22627A1 - Preparado vacunal para la inmuno-castración reversible de mamíferos - Google Patents
Preparado vacunal para la inmuno-castración reversible de mamíferosInfo
- Publication number
- CU22627A1 CU22627A1 CU1996120A CU1996120A CU22627A1 CU 22627 A1 CU22627 A1 CU 22627A1 CU 1996120 A CU1996120 A CU 1996120A CU 1996120 A CU1996120 A CU 1996120A CU 22627 A1 CU22627 A1 CU 22627A1
- Authority
- CU
- Cuba
- Prior art keywords
- gnrh
- mammals
- hormone
- castration
- pro
- Prior art date
Links
- 241000124008 Mammalia Species 0.000 title abstract 3
- 230000002441 reversible effect Effects 0.000 title 1
- 229960005486 vaccine Drugs 0.000 title 1
- 239000005556 hormone Substances 0.000 abstract 2
- 229940088597 hormone Drugs 0.000 abstract 2
- 230000028993 immune response Effects 0.000 abstract 2
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 108010078791 Carrier Proteins Proteins 0.000 abstract 1
- 241000282887 Suidae Species 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 125000003630 glycyl group Chemical group [H]N([H])C([H])([H])C(*)=O 0.000 abstract 1
- 230000002130 immunocastration Effects 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 125000001500 prolyl group Chemical group [H]N1C([H])(C(=O)[*])C([H])([H])C([H])([H])C1([H])[H] 0.000 abstract 1
- 239000003488 releasing hormone Substances 0.000 abstract 1
- 241000894007 species Species 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Endocrinology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invención está relacionada con el campo de la Ingeniería y la Biotecnología y en particular con el uso de un péptido derivado de la GnRH para la inmunocastración de mamíferos. En mamíferos, se ha ensayado la vacunación con la hormona liberadora de la gonodatropina (GnRH, siglas en inglés), con el fin de provocar una respuesta inmune que neutralice la actividad de dicha hormona. La presente invención se refiere al uso de una variante de la GnRH de mamíferos que presenta un cambio de un residuo glicina por un residuo prolina en la posición 6: pGlu-His-Trp-Ser-Tyr-Pro-Leu-Arg-Pro-Gly Este cambio ha mostrado inducir una respuesta inmune superior a la de la GnRH natural, cuando ambas están acopladas a una misma proteína portadora, en experimentos realizados en cerdos. Este mismo resultado es de esperar en cualquier otro mamífero ya que esta hormona es conservada en todas las especies.
Priority Applications (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU1996120A CU22627A1 (es) | 1996-12-17 | 1996-12-17 | Preparado vacunal para la inmuno-castración reversible de mamíferos |
| BR9713735-9A BR9713735A (pt) | 1996-12-17 | 1997-12-17 | Vacina para imunocastração reversìvel de mamìferos |
| PCT/CU1997/000008 WO1998027111A1 (es) | 1996-12-17 | 1997-12-17 | Vacuna para la inmuno-castración reversible de mamíferos |
| EP97947684A EP0959079A1 (en) | 1996-12-17 | 1997-12-17 | Vaccine for the reversible immunocastration of mammals |
| CA002275440A CA2275440A1 (en) | 1996-12-17 | 1997-12-17 | Vaccine for the reversible immunocastration of mammals |
| ARP970105935A AR009840A1 (es) | 1996-12-17 | 1997-12-17 | Preparado vacunal para la inmunocastracion revesible de mamiferos |
| AU53975/98A AU736538B2 (en) | 1996-12-17 | 1997-12-17 | Vaccine preparation for the reversible immunocastration of mammals |
| KR10-1999-7005452A KR100461732B1 (ko) | 1996-12-17 | 1997-12-17 | 포유동물의 가역적인 면역적 거세를 위한 백신 |
| UY24815A UY24815A1 (es) | 1996-12-17 | 1997-12-17 | Preparado vacunal para la inmuno-castración reversible de mamiferos. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU1996120A CU22627A1 (es) | 1996-12-17 | 1996-12-17 | Preparado vacunal para la inmuno-castración reversible de mamíferos |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU22627A1 true CU22627A1 (es) | 2000-12-22 |
Family
ID=5459402
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU1996120A CU22627A1 (es) | 1996-12-17 | 1996-12-17 | Preparado vacunal para la inmuno-castración reversible de mamíferos |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0959079A1 (es) |
| KR (1) | KR100461732B1 (es) |
| AR (1) | AR009840A1 (es) |
| AU (1) | AU736538B2 (es) |
| BR (1) | BR9713735A (es) |
| CA (1) | CA2275440A1 (es) |
| CU (1) | CU22627A1 (es) |
| UY (1) | UY24815A1 (es) |
| WO (1) | WO1998027111A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CU23204A1 (es) * | 2002-12-27 | 2007-05-18 | Ct Ingenieria Genetica Biotech | Combinaciones de factores reguladores del crecimiento y hormonas para el tratamiento de neoplasias |
| CU23739A1 (es) * | 2008-09-30 | 2011-12-28 | Ct Ingenieria Genetica Biotech | Composición farmacéutica utilizando combinaciones de variantes de la hormona liberadora de las gonadotropinas (gnrh) como inmunógeno |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ220932A (en) * | 1986-07-03 | 1990-05-28 | Victoria State | Composition comprising an antigenic substance, such as lhrh, conjugated to at least two different carriers and method of immunological castration and spaying |
| AU602187B2 (en) * | 1987-01-14 | 1990-10-04 | Commonwealth Scientific And Industrial Research Organisation | Anti-reproductive hormone |
| KR100257214B1 (ko) * | 1991-03-01 | 2000-05-15 | 데스꼴롱그 티에리 | 거세되지 않은 수컷가축의 고기의 관능적 품질을 개선하기 위한 방법 |
| AU634379B2 (en) * | 1991-04-29 | 1993-02-18 | Csl Limited | Recombinant immunocastration vaccine |
-
1996
- 1996-12-17 CU CU1996120A patent/CU22627A1/es unknown
-
1997
- 1997-12-17 EP EP97947684A patent/EP0959079A1/en not_active Withdrawn
- 1997-12-17 AU AU53975/98A patent/AU736538B2/en not_active Ceased
- 1997-12-17 BR BR9713735-9A patent/BR9713735A/pt not_active IP Right Cessation
- 1997-12-17 KR KR10-1999-7005452A patent/KR100461732B1/ko not_active Expired - Fee Related
- 1997-12-17 WO PCT/CU1997/000008 patent/WO1998027111A1/es not_active Ceased
- 1997-12-17 AR ARP970105935A patent/AR009840A1/es unknown
- 1997-12-17 UY UY24815A patent/UY24815A1/es not_active IP Right Cessation
- 1997-12-17 CA CA002275440A patent/CA2275440A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AR009840A1 (es) | 2000-05-03 |
| UY24815A1 (es) | 2001-03-16 |
| KR20000057647A (ko) | 2000-09-25 |
| EP0959079A1 (en) | 1999-11-24 |
| KR100461732B1 (ko) | 2004-12-14 |
| AU5397598A (en) | 1998-07-15 |
| AU736538B2 (en) | 2001-08-02 |
| WO1998027111A1 (es) | 1998-06-25 |
| CA2275440A1 (en) | 1998-06-25 |
| BR9713735A (pt) | 2000-03-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE117399A1 (es) | CICATRIZACION DE FRACTURAS UTILIZANDO ANALOGOS DE PTHrP | |
| DE69838143D1 (de) | Antimikrobielle peptide | |
| ATE338118T1 (de) | Neues peptid, apoep1.b, zusammensetzungen und verwendungen davon | |
| ES2564463T3 (es) | Péptidos antigénicos de Neisseriales | |
| DE60019458D1 (de) | Stabilisierendes verdünnungsmittel für polypeptide und antigene | |
| ES2063965T3 (es) | Vacunas para haemophilus influenzae no tipificable. | |
| DK0535091T3 (da) | Knogleinducerende farmaceutiske formuleringer | |
| PT941315E (pt) | Proteinas de stress contendo proteinas de fusao para induzir respostas imunitarias | |
| NZ333999A (en) | GnRH-leukotoxin chimeric proteins for use in vaccines | |
| PT935609E (pt) | Composicoes cristalizaveis que contem um complexo entre o dominio de protease ns3 do virus da hepatite c e ns4a cristais resultantes | |
| LU92488I2 (fr) | Dimethyl fumarate | |
| ATE324116T1 (de) | Ein antigen und ein adjuvans-peptid enthaltende impfstoffzusammensetzung | |
| CO5700784A2 (es) | Polipeptidos de virus de papiloma humano y composiciones in- munogenas | |
| ES2029171A6 (es) | Un procedimiento para preparar un polipeptido virico de hepatitis no a y no b post-transfusional (pt-nanbh) | |
| TR199802534T2 (xx) | Leptin (OB Protein) fragmanlar� | |
| BR0205983A (pt) | fármacos peptìdicos antiangiogênicos | |
| WO1999040113A3 (fr) | Lipopeptides contenant un fragment de l'interferon et leur utilisation dans des compositions pharmaceutiques | |
| ATE536878T1 (de) | Herstellung einer therapeutischen zusammensetzung | |
| NZ332565A (en) | Nucleic acid and amino acid sequences relating to helicobacter pylori and vaccine compositions thereof | |
| NO991995L (no) | Nukleinsyre- og aminosyresekvenser relatert til Heliobacter pylori og vaksinesammensetninger derav | |
| CU22627A1 (es) | Preparado vacunal para la inmuno-castración reversible de mamíferos | |
| ATE355302T1 (de) | N-substituierte d-aminosäuren enthaltende peptide,zur prävention der beta-strang assoziation | |
| AR004497A1 (es) | Un análogo hexapéptido cíclico de somatostatina, procedimiento para prepararlos y las composiciones farmacéuticas que los contienen y el uso de dicho hexapéptido para la preparación de una composición farmacéutica. | |
| BRPI0606445A2 (pt) | inibidores de hipersecreÇço de mucina e mÉtodos de uso | |
| AR026068A1 (es) | Peptidos modificados y peptidomimeticos para el uso en inmunoterapia. |